On November 18, James Tyminski and Taskeen Aman published “How Gen AI Is Reshaping E-Discovery in IP-Heavy Industries” in Law.com’s Legaltech News. The following is an excerpt:
As electronic discovery continues to evolve, pharmaceutical and technology companies—particularly those navigating the complexities of patent litigation—face a rapidly changing technological landscape that is increasingly influenced by artificial intelligence (AI) tools. Discovery in U.S. litigation, especially document review, can often be a lengthy and expensive process. This naturally raises the question: why not leverage AI tools more aggressively to streamline the process? Generative AI (gen AI) promises a faster, smarter, and more scalable document review, but not without complications.
Click here to access the article.